Publication details
Neoadjuvant chemotherapy for primary advanced ovarian cancer
| Authors | |
|---|---|
| Year of publication | 2013 |
| Type | Article in Periodical |
| Magazine / Source | Biomedical Papers |
| MU Faculty or unit | |
| Citation | |
| Web | http://biomed.papers.upol.cz/artkey/pri-990000-0600_VOLUME_157_Supplement_2.php |
| Field | Applied statistics, operation research |
| Keywords | neoadjuvant chemotherapy; ovarian cancer |
| Description | Primary debulking surgery before adjuvant chemotherapy (ACT) is the standard of care for patients with advanced ovarian cancer but neoadjuvant CT (NACT) is an alternative therapeutic approach in stage IIIC or IV disease. We evaluated our patients with NACT and its influence on radicality of surgery and overall survival (OS). We evaluated 138 women treated for advanced ovarian cancer of stage FIGO IIIC-IV not suitable for primary debulking surgery (PDS) because of unresectable tumor or poor performance status. All women underwent laparoscopic evaluation – confirming inoperable advanced ovarian cancer of stage IIIC-IV. After the NACT of 3-4 series was provided this was followed by laparoscopic reevaluation. |